Name: MAP kinase-interacting serine/threonine-protein kinase 1/2 Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

MAP kinase-interacting serine/threonine-protein kinase 1/2 Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Tomivosertib	IC50	6.0 ^[1]
	(4-Methylpiperazin-1-yl)-[4-[3-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazin-6-yl]phenyl]methanone	IC50	1990.0 ^[1]
	[4-[3-(4-Chlorophenyl)imidazo[1,2-a]pyrazin-6-yl]phenyl]-(4-methylpiperazin-1-yl)methanone	IC50	759.0 ^[1]
	CID 118598634	IC50	73.0 ^[1]
	N-[6-[(8-Chloro-1,5-dioxospiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide	IC50	0.31 ^[1]
Rows per page: 1–5 of 49

References

This online resource may be cited as follows

MLA	"Quest Database™ MAP kinase-interacting serine/threonine-protein kinase 1/2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/map-kinase-interacting-serine-threonine-protein-kinase-1-2-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 15). Quest Database™ MAP kinase-interacting serine/threonine-protein kinase 1/2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-interacting-serine-threonine-protein-kinase-1-2-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan